Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop

被引:16
作者
Adrichem, Max E. [1 ]
Eftimov, Filip [1 ]
van Schaik, Ivo N. [1 ]
机构
[1] Acad Med Ctr Amsterdam, Dept Neurol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
关键词
CIDP; IVIg; long-term treatment; RANDOMIZED CONTROLLED TRIAL; NEONATAL FC-RECEPTOR; IMMUNE GLOBULIN; IVIG RESPONSIVENESS; POLYNEUROPATHY; INFUSION; THERAPY; CIDP; IGG; METHYLPREDNISOLONE;
D O I
10.1111/jns.12176
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Intravenous immunoglobulin (IVIg) is often used as preferred treatment in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Several studies highlighted the short-term efficacy of IVIg for CIDP yet many patients need maintenance therapy. Notwithstanding the fact IVIg has been used for over 30 years in CIDP, there is only limited evidence to guide dosage and interval during maintenance treatment. The variation in disease course, lack of biomarkers, and fear of deterioration after stopping IVIg makes long-term treatment challenging. Recent studies suggest a proportion of patients receive unnecessary IVIg maintenance treatment. This review provides an overview of the use of IVIg for CIDP treatment, focusing on evidence for long-term IVIg use.
引用
收藏
页码:121 / 127
页数:7
相关论文
共 50 条
  • [21] Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy
    McCrone, P
    Chisholm, D
    Knapp, M
    Hughes, R
    Comi, G
    Dalakas, MC
    Illa, I
    Kilindireas, C
    Nobile-Orazio, E
    Swan, A
    Van den Bergh, P
    Willison, HJ
    EUROPEAN JOURNAL OF NEUROLOGY, 2003, 10 (06) : 687 - 694
  • [22] Subcutaneous immunoglobulin. Treatment in chronic inflammatory demyelinating polyradiculoneuropathy
    Nogues, Martin A.
    Varela, Francisco J.
    Seminario, Gisela
    Insua, Maria C.
    Bezrodnik, Liliana
    MEDICINA-BUENOS AIRES, 2016, 76 (01) : 36 - 39
  • [23] Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies
    Tracy, Jennifer A.
    Dyck, P. James B.
    CURRENT OPINION IN NEUROLOGY, 2010, 23 (03) : 242 - 248
  • [24] Chronic Inflammatory Demyelinating Polyradiculoneuropathy
    Hughes, Richard
    JOURNAL OF CLINICAL IMMUNOLOGY, 2010, 30 : S70 - S73
  • [25] Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis
    Colin Anderson-Smits
    Mary E. Ritchey
    Zhongwen Huang
    Shailesh Chavan
    Nizar Souayah
    Hakan Ay
    J. Bradley Layton
    Neurology and Therapy, 2023, 12 : 1119 - 1132
  • [26] Chronic inflammatory demyelinating polyradiculoneuropathy
    Ehler, E.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2018, 81 (03) : 252 - 264
  • [27] Chronic inflammatory demyelinating polyradiculoneuropathy
    Franques, J.
    Azulay, J. -P.
    Pouget, J.
    Attarian, S.
    REVUE DE MEDECINE INTERNE, 2010, 31 (06): : 411 - 416
  • [28] Timing and Course of Clinical Response to Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
    Latov, Norman
    Deng, Chunqin
    Dalakas, Marinos C.
    Bril, Vera
    Donofrio, Peter
    Hanna, Kim
    Hartung, Hans-Peter
    Hughes, Richard A. C.
    Merkies, Ingemar S. J.
    van Doorn, Peter A.
    ARCHIVES OF NEUROLOGY, 2010, 67 (07) : 802 - 807
  • [29] Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach
    Stino, Amro M.
    Naddaf, Elie
    Dyck, Peter J.
    Dyck, P. James B.
    MUSCLE & NERVE, 2021, 63 (02) : 157 - 169
  • [30] Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy
    Bunschoten, Carina
    Jacobs, Bart C.
    Van den Bergh, Peter Y. K.
    Cornblath, David R.
    van Doorn, Pieter A.
    LANCET NEUROLOGY, 2019, 18 (08) : 784 - 794